Compare Aspira Biosystems vs Sangamo Therapeutics
Customers evaluate the quality of Aspira Biosystems's products using the following success metrics.
Overview
Aspira Biosystems is based in United States
Aspira Biosystems is developing technology that enables the capture, with very high specificity, of targeted proteins. Aspira is actively seeking academic and commercial partners to develop therapeutic, medical research and industrial applications based on Partial Molecular Imprinting (PMI), our patented protein capture platform.
Sangamo Therapeutics is 29 yrs old and is based in United States.
Sangamo Therapeutics is focused on translating science into genomic medicines with the potential to transform patients' lives using the company's platform technologies in genome editing, gene therapy, gene regulation, and cell therapy.
Demo Video
Leadership
Chin-Shiou Huang (Chief Security Officer)
Edward Rebar (Chief Technology Officer)
Investors
Alloy Ventures and Archangel BioVentures
AAC Capital Partners, LODH Private Equity Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Aspira Biosystems has not claimed their profile.
Work for Aspira Biosystems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Aspira Biosystems?
Claim your profile now.
Information not available because Sangamo Therapeutics has not claimed their profile.
Work for Sangamo Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Sangamo Therapeutics?
Claim your profile now.
News & Analysis
Aspira Biosystems has not been mentioned in our research.
Sangamo Therapeutics has been mentioned in our research 1 time.
